Surface plasmon enhanced drug efficacy using core-shell Au@SiO2 nanoparticle carrier

Area of Science:

• Nanotechnology
• Biomedical Engineering
• Photochemistry

Background:

• Methylene blue (MB) is a photosensitizer used in various applications.
• Gold nanorods (Au) exhibit unique plasmonic properties.
• Combining photosensitizers with plasmonic nanoparticles can enhance therapeutic effects.

Purpose of the Study:

• To investigate the enhanced efficacy of methylene blue (MB) when incorporated into gold-core/silica-shell nanoparticles (Au@(SiO2-MB) NPs).
• To elucidate the role of the plasmonic effect versus the photothermal effect in the observed enhancement.
• To identify critical factors for maximizing the plasmonic enhancement of drug efficacy.

Main Methods:

• Synthesis of Au-core/SiO2-shell nanoparticles with incorporated MB.
• Irradiation of Au@(SiO2-MB) NPs with light to induce reactive oxygen species (ROS) generation.
• Assessment of cell viability to quantify the therapeutic effect.
• Analysis to differentiate between photothermal and plasmonic effects.

Main Results:

• Au@(SiO2-MB) NPs significantly decreased cell viability upon light irradiation.
• The plasmonic effect, not the photothermal effect, was identified as the primary driver of enhanced efficacy.
• Optimal efficacy requires close spatial proximity between Au and MB, and an energy match between MB absorption and Au surface plasmon resonance.

Conclusions:

• The plasmonic effect of gold nanoparticles significantly enhances the photosensitizing efficacy of methylene blue.
• Spatial arrangement and spectral overlap are crucial for maximizing plasmonic enhancement in nanomedicine.
• Au@(SiO2-MB) NPs represent a promising platform for enhanced photodynamic therapies.